CAR-BCMA T Cells
CT053-MM-01
Phase 2 mab active
Quick answer
CAR-BCMA T Cells for Multiple Myeloma is a Phase 2 program (mab) at First Tracks Biotherapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- First Tracks Biotherapeutics
- Indication
- Multiple Myeloma
- Phase
- Phase 2
- Modality
- mab
- Status
- active